Stay informed with the latest litigation news. Explore now
Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor - EP3184526B1
EP3184526
- Application Number
- EP16197502A
- Filing Date
- Dec 12, 2006
- Status
- Granted And Under Opposition
- Aug 31, 2018
- Grant Date
- Oct 3, 2018
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP3184526B1 was granted to Incyte on Oct 3, 2018 following the initial filing on Dec 12, 2006 under the application number EP16197502A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary
Patent Family New
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents